Research library / Longevity compounds
CC Small or few human trials. Promising, not proven. How we grade →RCT (pilot) · 40 adults over 65, 13 weeks
Spermidine Mitigates Immune Cell Senescence and Boosts Vaccine Responses in Healthy Older Adults: A Pilot Study
G Alsaleh, M Ali, A Kayvanjoo, F Liu, T Moreau, S Bibi et al. Aging Cell. 2026.
- In plain language
- 6 mg a day was well tolerated; antibody responses improved only in vaccine non-responders.
- Limits
- Small pilot, subgroup result; The Longevity Labs supplied product and part-funded; authors consult for it.
- Which of our grades it feeds
- DD Mostly mechanistic or early data. Shown openly. How we grade →Science summary: Spermidine
- Source
- doi.org/10.1111/acel.70545 · PubMed 42169618 · Free full text
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.